Progyny Inc (PGNY)
32.28
+0.22
(+0.67%)
USD |
NASDAQ |
May 01, 16:00
32.28
0.00 (0.00%)
After-Hours: 18:44
Progyny Cash from Financing (Quarterly): -5.025M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.025M |
| September 30, 2023 | -2.362M |
| June 30, 2023 | -1.839M |
| March 31, 2023 | -1.846M |
| December 31, 2022 | -2.786M |
| September 30, 2022 | -1.228M |
| June 30, 2022 | -2.078M |
| March 31, 2022 | -1.772M |
| December 31, 2021 | -3.314M |
| September 30, 2021 | -3.06M |
| Date | Value |
|---|---|
| June 30, 2021 | -4.824M |
| March 31, 2021 | -2.497M |
| December 31, 2020 | -2.084M |
| September 30, 2020 | -1.608M |
| June 30, 2020 | -2.363M |
| March 31, 2020 | -0.194M |
| December 31, 2019 | 80.48M |
| September 30, 2019 | 1.907M |
| June 30, 2019 | -4.18M |
| March 31, 2019 | 6.333M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-5.025M
Minimum
Dec 2023
80.48M
Maximum
Dec 2019
2.070M
Average
-2.084M
Median
Dec 2020
Cash from Financing (Quarterly) Benchmarks
| Delcath Systems Inc | 0.001M |
| Star Equity Holdings Inc | 0.987M |
| Exact Sciences Corp | 10.04M |
| Illumina Inc | -27.00M |
| CytoSorbents Corp | 12.21M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 37.66M |
| Cash from Investing (Quarterly) | -93.41M |
| Free Cash Flow | 185.17M |
| Free Cash Flow Per Share (Quarterly) | 0.366 |
| Free Cash Flow to Equity (Quarterly) | 36.98M |
| Free Cash Flow to Firm (Quarterly) | 36.98M |
| Free Cash Flow Yield | 5.70% |